Pax6 Overexpression in Primate Neural Stem Cells

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Somatic stem cells, such as brain stem cells, lose their differentiation potential when cultured for extended periods, and transplantation of stem cell-derived neural cells is confounded by the tumorigenic potential of undifferentiated neuroepithelial cells.

Innovation Solution

Overexpression of the transcription factor Pax6 in primate somatic stem cells maintains their undifferentiated state and suppresses the expression of Sox1 and Oct4, allowing for prolonged proliferation without differentiation and reducing the risk of tumor formation upon transplantation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If somatic stem cells are cultured for extended periods, then cell proliferation is maintained, but differentiation potential is lost

Engineering Contradiction:

Improvecell proliferationVSAvoiddifferentiation potential

Core Design Contradiction:

ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by modulating the expression levels of specific transcription factors (Oct4, Nanog, Sox2) to maintain stem cell characteristics during prolonged culture. By adjusting these molecular parameters, the cells can proliferate extensively while retaining their differentiation potential, effectively resolving the contradiction between productivity and adaptability.

Inventive Principle:

Principle #35Parameter changes

2Ease of operation

If undifferentiated neuroepithelial cells are transplanted, then cell replacement therapy is provided, but tumorigenic potential increases

Engineering Contradiction:

Improvetransplantation capabilityVSAvoidtumorigenic potential

Core Design Contradiction:

Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by pre-differentiating the stem cells into committed neural lineages before transplantation. This preliminary differentiation step removes the tumorigenic undifferentiated cells while preserving the therapeutic benefits, thus resolving the contradiction between ease of operation and harmful factors.

Inventive Principle:

Principle #10Preliminary action

3Duration of action of stationary object

If stem cells are maintained in undifferentiated state, then self-renewal is enhanced, but tumorigenic risk increases

Engineering Contradiction:

Improveself-renewal capacityVSAvoidtumorigenic risk

Core Design Contradiction:

Duration of action of stationary objectVSObject-affected harmful factors

Solution Approach 1:

The patent applies dynamics by implementing a controlled transition from undifferentiated to differentiated states. The system dynamically regulates transcription factor expression to maintain self-renewal capacity when needed, then directs differentiation to eliminate tumorigenic risk, resolving the contradiction between duration of action and harmful factors.

Inventive Principle:

Principle #15Dynamics

Data Source

PatentUS8895301B2Exogenous Pax6 nucleic acid expression in primate neural stem cells maintains proliferation without differentiation

Publication Date: 2014.11.25 WISCONSIN ALUMNI RES FOUND

AI summary

A transcription factor both necessary and sufficient for human neuroectoderm specification, Pax6, as well as applications thereof, is disclosed.